ERBB2 and obesity due to melanocortin 4 receptor deficiency: In conclusion, the current study demonstrates that obesity-associated systemic factors suppress ERβ expression in breast cancer cells that overexpress HER2, revealing a new potential mechanism by which obesity promotes a more aggressive disease.